Individuals with certain types of bacteria in their gut may be more likely to respond well to cancer immunotherapy, researchers found in a study of patients with metastatic melanoma.
Individuals with certain types of bacteria in their gut may be more likely to respond well to cancer immunotherapy, researchers found in a study of patients with metastatic melanoma.